Nevakar's Ephedrine Sulfate Injection Receives the US FDA's Approval as Ready-To-Use Vials
Shots:
- Nevakar received US FDA’s approval to market Ephedrine Sulfate Injection (50mg/10 ml) in a ready to use vial presentation and it is the 1st approval under collaboration b\w Nevakar and Endo for the development of sterile injectable product in the US and Canada
- Nevakar to develop and obtain FDA approval for these products and Par Pharmaceuticals Sterile Products division will launch and distribute the products
- The company is focused on developing and commercializing innovative products to address unmet medical needs- thereby improving patient care and quality of life
Ref: PRNewswire | Image: Nevakar
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com